ARCHIVES

FDA to refer false statements by regulated companies to SEC.

This article is from The Cancer Letter archive.

Vol. 30 No. 09 | February 27, 2004

Download PDF Visit The Full Archive

Related Articles

Construction Report Scheduled for NCAB

August 25, 1978

Smokers Who Quit Live Longer Than Those Who Spit-Study

May 25, 2007

CT Scanning Use, Costs, Controls Debated By NCAB

October 7, 1977

International Group Plans Survey On Thrombosis Risk

July 27, 2001

Arthur Upton New Name In Director Race; Califano Meets With Prospects

May 6, 1977

Rauscher Responds To Criticism

March 21, 1975